Pfizer confirms Allergan merger deal creating the world's largest drug company
The company born from this merger will retain the Pfizer name, but change its fiscal headquarters. The combined company, with more than $320 billion market capitalization, will have an income of about $63 billion, according to the 2014 results. The current CEO of Pfizer, Ian Read, will lead the new company, while Allergan CEO, Brent Saunders, will be second in line.
Reuters
Pfizer, the company that owns Viagra, and Allergan, the maker of Botox, have merged to create the world’s largest health-related group ahead of Johnson & Johnson. The transaction is valued at $160 billion.
The company born from this merger will retain the Pfizer name, but change its fiscal headquarters. The combined company, with more than $320 billion market capitalization, will have an income of about $63 billion, according to the 2014 results. The current CEO of Pfizer, Ian Read, will lead the new company, while Allergan CEO, Brent Saunders, will be second in line.
